Form 8-K - Current report:
SEC Accession No. 0001193125-24-251268
Filing Date
2024-11-05
Accepted
2024-11-05 16:25:30
Documents
14
Period of Report
2024-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d825275d8k.htm   iXBRL 8-K 25580
2 EX-99.1 d825275dex991.htm EX-99.1 118927
  Complete submission text file 0001193125-24-251268.txt   276515

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctkb-20241105.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctkb-20241105_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctkb-20241105_pre.xml EX-101.PRE 10806
16 EXTRACTED XBRL INSTANCE DOCUMENT d825275d8k_htm.xml XML 3505
Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Filer) CIK: 0001831915 (see all company filings)

EIN.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40632 | Film No.: 241427859
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)